Grayscale Research has spotlighted 20 digital assets expected to outperform in the fourth quarter, emphasizing factors like probable catalysts and technological advancements that may drive their success.
Grayscale Expands Digital Asset Portfolio for Q4
Considerations such as probable catalysts, network adoption, possible risk factors, and so on are taken into consideration by the research arm of the top asset management while assembling its list.
Grayscale Research has expanded their digital asset portfolio by six items during this water. Sui (SUI), Optimism (OP), Helium (HNT), Bittensor (TAO), UMA Protocol (UMA), and Celo (CELO) are all part of this.
High-Performance Infrastructure and Transaction Speed
The Sui and Optimism, according to Grayscale, are designed to symbolize high-performance infrastructure, as reported by U.Today.
In terms of transaction speed, it was noticed that third-generation blockchain Sui has beaten "Ethereum killer" Solana. The Solana blockchain's native token, SOL, is also included here. There was some optimism expressed over the "Superchain" network of chains that use the same open-source technological stack.
Oracle Networks and Stablecoin Adoption
With Polymarket's meteoric rise to prominence, oracle network UMA stands to gain ground. Stablecoin adoption is on the rise, which might be good news for Celo.
Helium, a blockchain-based network for enabling IoT devices, has been integrated into Grayscale because of its consistent revenue generation capabilities.
AI Integration with Blockchain Technology
Last but not least, Bittensor might be considered an AI play. The goal of the project is to combine AI with blockchain technology in order to help decentralize the former.
Market Shakeup: RAY and RUNE Exit the Top 20
Coins like Raydium (RAY) and ThorChain (RUNE) have fallen out of the top 20 at the same time.


Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sam Altman Reaffirms OpenAI’s Long-Term Commitment to NVIDIA Amid Chip Report
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment




